Aneliya Parvanova

Publication Activity (10 Years)

Years Active: 2021-2021
Publications (10 Years): 2

Top Topics

Diabetic Nephropathy

Randomized Controlled Trial

Combination Therapy

Top Venues

Acta diabetologica

This page only lists publications with an associated author ORCID identifier.

Publications

Piero Ruggenenti, Monica Cortinovis, Aneliya Parvanova, Matias Trillini, Ilian P Iliev, Antonio Carlo Bossi, Antonio Belviso, Maria C Aparicio, Roberto Trevisan, Stefano Rota, Annalisa Perna, Tobia Peracchi, Nadia Rubis, Davide Martinetti, Silvia Prandini, Flavio Gaspari, Fabiola Carrara, Salvatore De Cosmo, Giancarlo Tonolo, Ruggero Mangili, Guiseppe Remuzzi, null null
Preventing microalbuminuria with benazepril, valsartan, and benazepril-valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study. PLoS medicine 18 (7) (2021)
Fabiola Carrara, Piero Ruggenenti, Annalisa Perna, Ilian Petrov Iliev, Flavio Gaspari, Silvia Ferrari, Nadia Stucchi, Antonio Carlo Bossi, Roberto Trevisan, Guiseppe Remuzzi, Aneliya Parvanova
Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial. Acta diabetologica (2021)